WALTHAM, Mass., Feb. 29, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today that it will present at Cowen and Company's upcoming 32nd Annual Health Care Conference on March 7, 2012 at 9:20 a.m. Eastern Time. Eric Bouvier, President and CEO of the Company, will present an overview of BG Medicine and updates on the Company's portfolio of cardiovascular diagnostic tests.
